Pasquali, Matheus A.
Harlow, Bernard L.
Soares, Claudio N.
Otto, Michael W.
Cohen, Lee S.
Minuzzi, Luciano
Gelain, Daniel P.
Moreira, Jose Claudio F.
Frey, Benicio N.
Funding for this research was provided by:
National Institute of Mental Health (R01-MH-50013 and R01-MH-69732)
Article History
Received: 19 November 2016
Accepted: 19 May 2017
First Online: 26 May 2017
Compliance with ethical standards
:
: Dr. Otto has served as a paid consultant for MicroTransponder Inc., Concert Pharmaceuticals, and ProPhase; provided expert consensus opinion for Otsuka Pharmaceuticals, received royalty support for use of the SIGH-A from ProPhase, and received book royalties from Oxford University Press, Routledge, and Springer. Dr. Cohen has received research support from AstraZeneca Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Cephalon, Inc., Forest Laboratories, Inc., GlaxoSmithKline, National Institute on Aging, National Institutes of Health, National Institute of Mental Health, Ortho-McNeil Janssen, Pfizer Inc., and Sunovion Pharmaceuticals, Inc. He has done advisory/consulting activities with Noven Pharmaceuticals, and PamLab LLC. Dr. Gelain has received grants from Foundation For Supporting Research of Rio Grande do Sul, Brazil (FAPERGS: PIPG 0427-2551/14-0; and PqG 12099/8), and National Council for Scientific and Technological Development, Brazil (PVE 400437/2013-9). Dr. Moreira has received grants from Foundation For Supporting Research of Rio Grande do Sul, Brazil (FAPERGS: PIPG 0427-2551/14-0; and FAPERGS: PG 12/1060-6), and National Council for Scientific and Technological Development, Brazil (CNPq: 470973/2012-9). Dr. Frey has received grant/research support from Alternative Funding Plan Innovations Award, Brain and Behavior Research Foundation, Canadian Institutes of Health Research, Hamilton Health Sciences Foundation, J.P. Bickell Foundation, Ontario Brain Institute, Ontario Mental Health Foundation, Society for Women’s Health Research, Eli Lilly, and Pfizer, and has received consultant and/or speaker fees from AstraZeneca, Bristol-Myers Squibb, Canadian Psychiatric Association, CANMAT, Lundbeck, Pfizer, Servier, and Sunovion. Drs. Pasquali, Harlow, Soares, and Minuzzi report no financial relationships with commercial interests.